System Formulary Update
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
February 5, 2026
Situation
Removal of Andexxa from the health system formulary was approved at the January 2026 System Pharmacy and Therapeutics Committee meeting.
Background
The following medications were reviewed: Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo; andexanet alfa)
Assessment/Recommendation
Change effective: Tuesday, February 10, 2026